1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine structure
|
Common Name | 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine | ||
|---|---|---|---|---|
| CAS Number | 2095417-39-1 | Molecular Weight | 291.26 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C12H13N5O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine |
|---|
| Description | 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C12H13N5O4 |
|---|---|
| Molecular Weight | 291.26 |